Cannabidiol Product Dosing and Decision-Making in a National Survey of Individuals with Fibromyalgia.

ABSTRACT: Many people with fibromyalgia use cannabidiol (CBD) products despite limited rigorous evidence of benefit. In the current study, we conducted a secondary analysis of a cross-sectional survey of N = 878 people with fibromyalgia to investigate naturalistic decision making around CBD product choices, use patterns, and dosing. We subgrouped participants based on use of high-THC cannabis (HTC) in the past year (yes/no) as previous studies have shown that HTC use influences CBD use patterns. The study population was largely female (93.6%), white (91.5%) and 55.5 years old on average. Participants typically purchased CBD products online or at dispensaries, with purchasing driven by personal research (63%) rather than endorsement from medical professionals (16%). Overall, tinctures and topicals we

SUBMITTER: Boehnke KF 

PROVIDER: S-EPMC8716664 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature